Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4218

1.

Study design and protocol for evaluating the long-term prognosis of patients receiving his bundle pacing: A multicenter observational study.

Yanagisawa S, Inden Y, Kato H, Suzuki H, Fujita M, Ishikawa S, Kanzaki Y, Kamikubo Y, Murase Y, Murohara T, Shibata R.

J Arrhythm. 2019 Aug 16;35(5):760-765. doi: 10.1002/joa3.12229. eCollection 2019 Oct.

2.

Discovery and structure-activity relationship of plastoquinone analogs as anticancer agents against chronic myelogenous leukemia cells.

Ciftci HI, Bayrak N, Yıldırım H, Yıldız M, Radwan MO, Otsuka M, Fujita M, Tuyun AF.

Arch Pharm (Weinheim). 2019 Oct 11:e1900170. doi: 10.1002/ardp.201900170. [Epub ahead of print]

PMID:
31602720
3.

Impact of type of emergency department on the outcome of out-of-hospital cardiac arrest: a prospective cohort study.

Kaneda K, Yagi T, Todani M, Nakahara T, Fujita M, Kawamura Y, Oda Y, Tsuruta R.

Acute Med Surg. 2019 May 22;6(4):371-378. doi: 10.1002/ams2.423. eCollection 2019 Oct.

4.

Clinical implications of ALDH1A1 and ALDH1A3 mRNA expression in melanoma subtypes.

Samson JM, Ravindran Menon D, Smith DE, Baird E, Kitano T, Gao D, Tan AC, Fujita M.

Chem Biol Interact. 2019 Sep 30;314:108822. doi: 10.1016/j.cbi.2019.108822. [Epub ahead of print]

PMID:
31580832
5.

Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity.

I Ciftci H, O Radwan M, E Ozturk S, Ulusoy NG, Sozer E, E Ellakwa D, Ocak Z, Can M, F S Ali T, I Abd-Alla H, Yayli N, Tateishi H, Otsuka M, Fujita M.

Molecules. 2019 Sep 30;24(19). pii: E3535. doi: 10.3390/molecules24193535.

6.

Longitudinal study of individually adjusted fetal growth.

Fujita MM, Francisco RPV, Rodrigues AS, Zugaib M.

Int J Gynaecol Obstet. 2019 Sep 30. doi: 10.1002/ijgo.12987. [Epub ahead of print]

PMID:
31569271
7.

Gut and oral microbiota in autoimmune liver disease.

Abe K, Fujita M, Hayashi M, Okai K, Takahashi A, Ohira H.

Fukushima J Med Sci. 2019 Sep 27. doi: 10.5387/fms.2019-21. [Epub ahead of print]

8.

12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.

Takata R, Takahashi A, Fujita M, Momozawa Y, Saunders EJ, Yamada H, Maejima K, Nakano K, Nishida Y, Hishida A, Matsuo K, Wakai K, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Sasaki M, Shimizu A, Tanno K, Minegishi N, Suzuki K, Matsuda K, Kubo M, Inazawa J, Egawa S, Haiman CA, Ogawa O, Obara W, Kamatani Y, Akamatsu S, Nakagawa H.

Nat Commun. 2019 Sep 27;10(1):4422. doi: 10.1038/s41467-019-12267-6.

9.

Perioperative changes in oral bacteria number in patients undergoing cardiac valve surgery.

Suzuki H, Matsuo K, Okamoto M, Nakata H, Sakamoto H, Fujita M.

J Oral Sci. 2019 Sep 20. doi: 10.2334/josnusd.18-0380. [Epub ahead of print]

10.

Preparation and Application of Bioshell Calcium Oxide (BiSCaO) Nanoparticle-Dispersions with Bactericidal Activity.

Sato Y, Ishihara M, Nakamura S, Fukuda K, Takayama T, Hiruma S, Murakami K, Fujita M, Yokoe H.

Molecules. 2019 Sep 19;24(18). pii: E3415. doi: 10.3390/molecules24183415.

11.

GRWD1 directly interacts with p53 and negatively regulates p53 transcriptional activity.

Fujiyama H, Tsuji T, Hironaka K, Yoshida K, Sugimoto N, Fujita M.

J Biochem. 2019 Sep 23. pii: mvz075. doi: 10.1093/jb/mvz075. [Epub ahead of print]

PMID:
31545368
12.

Design, synthesis, and biological activity of Plastoquinone analogs as a new class of anticancer agents.

Bayrak N, Yıldırım H, Yıldız M, Radwan MO, Otsuka M, Fujita M, Tuyun AF, Ciftci HI.

Bioorg Chem. 2019 Nov;92:103255. doi: 10.1016/j.bioorg.2019.103255. Epub 2019 Sep 7.

PMID:
31542717
13.

Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis.

Eto A, Fujita M, Nishiyama Y, Saito T, Molina DM, Morikawa S, Saijo M, Shinmura Y, Kanatani Y.

Vaccine. 2019 Oct 16;37(44):6588-6593. doi: 10.1016/j.vaccine.2019.09.006. Epub 2019 Sep 17.

PMID:
31540810
14.

Diffuse Pulmonary Meningotheliomatosis with Sarcomatous Transformation in a Shiba Dog.

Michishita M, Fujiwara-Igarashi A, Suzuki S, Hatakeyama H, Machida Y, Yoshimura H, Yamamoto M, Azakami D, Ochiai K, Ishiwata T, Fujita M.

J Comp Pathol. 2019 Aug;171:1-5. doi: 10.1016/j.jcpa.2019.06.005. Epub 2019 Jul 30.

PMID:
31540619
15.

Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition.

Conley RB, Adib G, Adler RA, Akesson KE, Alexander IM, Amenta KC, Blank RD, Brox WT, Carmody EE, Chapman-Novakofski K, Clarke BL, Cody KM, Cooper C, Crandall CJ, Dirschl DR, Eagen TJ, Elderkin AL, Fujita M, Greenspan SL, Halbout P, Hochberg MC, Javaid M, Jeray KJ, Kearns AE, King T, Koinis TF, Koontz JS, Kuzma M, Lindsey C, Lorentzon M, Lyritis GP, Michaud LB, Miciano A, Morin SN, Mujahid N, Napoli N, Olenginski TP, Puzas JE, Rizou S, Rosen CJ, Saag K, Thompson E, Tosi LL, Tracer H, Khosla S, Kiel D.

J Bone Miner Res. 2019 Sep 20. doi: 10.1002/jbmr.3877. [Epub ahead of print]

PMID:
31538675
16.

A case of leptomeningeal metastases of human epidermal growth factor receptor 2-positive breast cancer that responded well to lapatinib plus capecitabine.

Nakao T, Okuda T, Fujita M, Kato A.

Surg Neurol Int. 2019 Jun 28;10:131. doi: 10.25259/SNI-106-2019. eCollection 2019.

17.

Anti-cancer activity of the cell membrane-permeable phytic acid prodrug.

Masunaga T, Murao N, Tateishi H, Koga R, Ohsugi T, Otsuka M, Fujita M.

Bioorg Chem. 2019 Nov;92:103240. doi: 10.1016/j.bioorg.2019.103240. Epub 2019 Sep 4.

PMID:
31525525
18.

Biomimetic Synthesis of Meroterpenoids by Dearomatization-Driven Polycyclization.

Powers Z, Scharf A, Cheng A, Yang F, Himmelbauer M, Mitsuhashi T, Barra L, Taniguchi Y, Kikuchi T, Fujita M, Abe I, Porco JA Jr.

Angew Chem Int Ed Engl. 2019 Sep 13. doi: 10.1002/anie.201910710. [Epub ahead of print]

PMID:
31515901
19.

Antiproliferative S-Trityl-l-Cysteine -Derived Compounds as SIRT2 Inhibitors: Repurposing and Solubility Enhancement.

Radwan MO, Ciftci HI, Ali TFS, Ellakwa DE, Koga R, Tateishi H, Nakata A, Ito A, Yoshida M, Okamoto Y, Fujita M, Otsuka M.

Molecules. 2019 Sep 10;24(18). pii: E3295. doi: 10.3390/molecules24183295.

20.

The Ethics of Cerebral Organoid Research: Being Conscious of Consciousness.

Sawai T, Sakaguchi H, Thomas E, Takahashi J, Fujita M.

Stem Cell Reports. 2019 Sep 10;13(3):440-447. doi: 10.1016/j.stemcr.2019.08.003. Review.

21.

Regulation of Ascorbate-Glutathione Pathway in Mitigating Oxidative Damage in Plants under Abiotic Stress.

Hasanuzzaman M, Bhuyan MHMB, Anee TI, Parvin K, Nahar K, Mahmud JA, Fujita M.

Antioxidants (Basel). 2019 Sep 9;8(9). pii: E384. doi: 10.3390/antiox8090384. Review.

22.

PD-L1 expression on tumor-infiltrating immune cells is highly associated with M2 TAM and aggressive malignant potential in patients with resected non-small cell lung cancer.

Sumitomo R, Hirai T, Fujita M, Murakami H, Otake Y, Huang CL.

Lung Cancer. 2019 Oct;136:136-144. doi: 10.1016/j.lungcan.2019.08.023. Epub 2019 Aug 31.

PMID:
31499335
23.

Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.

Sever B, Altıntop MD, Radwan MO, Özdemir A, Otsuka M, Fujita M, Ciftci HI.

Eur J Med Chem. 2019 Aug 28;182:111648. doi: 10.1016/j.ejmech.2019.111648. [Epub ahead of print]

PMID:
31493743
24.

Second-look arthroscopic findings of cartilage and meniscus repair after injection of adipose-derived regenerative cells in knee osteoarthrits: Report of two cases.

Onoi Y, Hiranaka T, Nishida R, Takase K, Fujita M, Hida Y, Fujishiro T, Okamoto K.

Regen Ther. 2019 Aug 24;11:212-216. doi: 10.1016/j.reth.2019.07.010. eCollection 2019 Dec.

25.

Cellulose-rich secondary walls in wave-swept red macroalgae fortify flexible tissues.

Martone PT, Janot K, Fujita M, Wasteneys G, Ruel K, Joseleau JP, Estevez JM.

Planta. 2019 Sep 3. doi: 10.1007/s00425-019-03269-1. [Epub ahead of print]

PMID:
31482328
26.

Comparative Physiological and Biochemical Changes in Tomato (Solanum lycopersicum L.) Under Salt Stress and Recovery: Role of Antioxidant Defense and Glyoxalase Systems.

Parvin K, Hasanuzzaman M, Bhuyan MHMB, Nahar K, Mohsin SM, Fujita M.

Antioxidants (Basel). 2019 Sep 1;8(9). pii: E350. doi: 10.3390/antiox8090350.

27.

Applicability of amino acid derivative reactivity assay for prediction of skin sensitization by combining multiple alternative methods to evaluate key events.

Yamamoto Y, Fujita M, Wanibuchi S, Sato A, Akimoto M, Katsuoka Y, Ono A, Kasahara T.

J Toxicol Sci. 2019;44(9):585-600. doi: 10.2131/jts.44.585.

28.

Assessing a polluted river environment by oxidative stress biomarker responses in caddisfly larvae.

Suzuki J, Nakano D, Imamura M, Yamamoto R, Fujita M.

Sci Total Environ. 2019 Aug 21;696:134005. doi: 10.1016/j.scitotenv.2019.134005. [Epub ahead of print]

PMID:
31465918
29.

Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Fujii Y, Takeda Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Yamamto K, Ogo A, Yanase T, Okamura S, Miyauchi S, Fujita M, Suzuki T, Umakoshi H, Ogasawara T, Tsuiki M, Naruse M; JPAS Study Group.

J Hum Hypertens. 2019 Aug 28. doi: 10.1038/s41371-019-0229-4. [Epub ahead of print]

PMID:
31462725
30.

Precipitation of test chemicals in reaction solutions used in the amino acid derivative reactivity assay and the direct peptide reactivity assay.

Yamamoto Y, Wanibuchi S, Sato A, Kasahara T, Fujita M.

J Pharmacol Toxicol Methods. 2019 Aug 22;100:106624. doi: 10.1016/j.vascn.2019.106624. [Epub ahead of print]

PMID:
31445998
31.

Single-drug approach with rivaroxaban: A case of successful anticoagulation against cancer-associated thrombosis.

Shioyama W, Oka T, Yasui T, Fujita M.

J Cardiol Cases. 2019 Jun 28;20(2):39-41. doi: 10.1016/j.jccase.2019.03.005. eCollection 2019 Aug.

32.

IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease.

Højen JF, Kristensen MLV, McKee AS, Wade MT, Azam T, Lunding LP, de Graaf DM, Swartzwelter BJ, Wegmann M, Tolstrup M, Beckman K, Fujita M, Fischer S, Dinarello CA.

Nat Immunol. 2019 Sep;20(9):1138-1149. doi: 10.1038/s41590-019-0467-1. Epub 2019 Aug 19.

PMID:
31427775
33.

Beliefs held by breast surgeons that impact the treatment decision process for advanced breast cancer patients: a qualitative study.

Ozeki-Hayashi R, Fujita M, Tsuchiya A, Hatta T, Nakazawa E, Takimoto Y, Akabayashi A.

Breast Cancer (Dove Med Press). 2019 Jul 17;11:221-229. doi: 10.2147/BCTT.S208910. eCollection 2019.

34.

Explicating physiological and biochemical responses of wheat cultivars under acidity stress: insight into the antioxidant defense and glyoxalase systems.

Bhuyan MHMB, Hasanuzzaman M, Mahmud JA, Hossain MS, Alam MU, Fujita M.

Physiol Mol Biol Plants. 2019 Jul;25(4):865-879. doi: 10.1007/s12298-019-00678-0. Epub 2019 May 21.

PMID:
31402814
35.

Structural Elucidation of Tenebrathin: Cytotoxic C-5-Substituted γ-Pyrone with a Nitroaryl Side Chain from Streptoalloteichus tenebrarius.

Hoshino S, Mitsuhashi T, Kikuchi T, Wong CP, Morita H, Awakawa T, Fujita M, Abe I.

Org Lett. 2019 Aug 16;21(16):6519-6522. doi: 10.1021/acs.orglett.9b02443. Epub 2019 Aug 6.

PMID:
31386371
36.

Japan ablation registry: cryoablation in atrioventricular nodal reentrant tachycardia ("JARCANRET study"): results from large multicenter retrospective investigation.

Okishige K, Okumura K, Tsurugi T, Yotsukura A, Nanbu T, Sugiura H, Sanada A, Kondo Y, Takano M, Keida T, Fujita M, Kamiya H, Tsuchiya K, Adachi K, Katoh Y, Hiroshima K, Yamamoto K, Ashikaga K, Hoshiyama T, Sasano T, Hirao K.

J Interv Card Electrophysiol. 2019 Jul 31. doi: 10.1007/s10840-019-00585-0. [Epub ahead of print]

PMID:
31367961
37.

Severe Fever with Thrombocytopenia Syndrome Complicated with Pseudomembranous Aspergillus Tracheobronchitis in a Patient without Apparent Risk Factors for Invasive Aspergillosis: A Case Report.

Sakaguchi K, Koga Y, Yagi T, Nakahara T, Todani M, Fujita M, Tsuruta R.

Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.3257-19. [Epub ahead of print]

38.

Neoadjuvant Chemotherapy Increases PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Esophageal Squamous Cell Carcinoma.

Fukuoka E, Yamashita K, Tanaka T, Sawada R, Sugita Y, Arimoto A, Fujita M, Takiguchi G, Matsuda T, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y.

Anticancer Res. 2019 Aug;39(8):4539-4548. doi: 10.21873/anticanres.13631.

PMID:
31366557
39.

Significance of Elevated HMGB1 Expression in Pituitary Apoplexy.

Okuda T, Fujita M, Kato A.

Anticancer Res. 2019 Aug;39(8):4491-4494. doi: 10.21873/anticanres.13624.

PMID:
31366550
40.

Current and future clinical utilities of Parkinson's disease and dementia biomarkers: can they help us conquer the disease?

Ho G, Takamatsu Y, Waragai M, Wada R, Sugama S, Takenouchi T, Fujita M, Ali A, Hsieh MH, Hashimoto M.

Expert Rev Neurother. 2019 Nov;19(11):1149-1161. doi: 10.1080/14737175.2019.1649141. Epub 2019 Aug 9.

PMID:
31359797
41.

Copper ions are novel therapeutic agents for uterine leiomyosarcoma.

Kakuda M, Matsuzaki S, Ueda Y, Shiomi M, Matsuzaki S, Kimura T, Fujita M, Egawa-Takata T, Kobayashi E, Serada S, Yoshino K, Naka T, Kimura T.

Am J Obstet Gynecol. 2019 Jul 24. pii: S0002-9378(19)30935-4. doi: 10.1016/j.ajog.2019.07.030. [Epub ahead of print]

PMID:
31351063
42.

Sepiapterin reductase inhibition selectively reduces inflammatory joint pain and increases urinary sepiapterin.

Fujita M, da Luz Scheffer D, Lenfers Turnes B, Cronin SJF, Latrémolière A, Costigan M, Woolf CJ, Latini A, Andrews NA.

Arthritis Rheumatol. 2019 Jul 27. doi: 10.1002/art.41060. [Epub ahead of print]

PMID:
31350812
43.

Melanoma to Vitiligo: The Melanocyte in Biology & Medicine-Joint Montagna Symposium on the Biology of Skin/PanAmerican Society for Pigment Cell Research Annual Meeting.

Leachman SA, Hornyak TJ, Barsh G, Bastian BC, Brash DE, Cleaver JE, Cooper CD, D'Orazio JA, Fujita M, Holmen SL, Indra AK, Kraemer KH, Le Poole IC, Lo RS, Lund AW, Manga P, Pavan WJ, Setaluri V, Stemwedel CE, Kulesz-Martin MF.

J Invest Dermatol. 2019 Jul 23. pii: S0022-202X(19)32550-3. doi: 10.1016/j.jid.2019.03.1164. [Epub ahead of print] No abstract available.

PMID:
31348921
44.

Synthesis and Application of Silver Nanoparticles (Ag NPs) for the Prevention of Infection in Healthcare Workers.

Nakamura S, Sato M, Sato Y, Ando N, Takayama T, Fujita M, Ishihara M.

Int J Mol Sci. 2019 Jul 24;20(15). pii: E3620. doi: 10.3390/ijms20153620. Review.

45.

Observation of two types of charge-density-wave orders in superconducting La2-xSrxCuO4.

Wen JJ, Huang H, Lee SJ, Jang H, Knight J, Lee YS, Fujita M, Suzuki KM, Asano S, Kivelson SA, Kao CC, Lee JS.

Nat Commun. 2019 Jul 22;10(1):3269. doi: 10.1038/s41467-019-11167-z.

46.

Association Between Acute Fall in Estimated Glomerular Filtration Rate After Treatment for Primary Aldosteronism and Long-Term Decline in Renal Function.

Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, Yoneda T, Kurihara I, Itoh H, Tsuiki M, Wada N, Ichijo T, Katabami T, Ogawa Y, Kawashima J, Yoshimoto T, Sone M, Inagaki N, Watanabe M, Kamemura K, Matsuda Y, Izawa S, Tanabe M, Tanabe A, Suzuki T, Naruse M; JPAS/JRAS Study Group.

Hypertension. 2019 Sep;74(3):630-638. doi: 10.1161/HYPERTENSIONAHA.119.13131. Epub 2019 Jul 22.

PMID:
31327258
47.

Repeated evolution of cytochrome P450-mediated spiroketal steroid biosynthesis in plants.

Christ B, Xu C, Xu M, Li FS, Wada N, Mitchell AJ, Han XL, Wen ML, Fujita M, Weng JK.

Nat Commun. 2019 Jul 19;10(1):3206. doi: 10.1038/s41467-019-11286-7.

48.

Metabolomic Analysis of Skeletal Muscle in Aged Mice.

Uchitomi R, Hatazawa Y, Senoo N, Yoshioka K, Fujita M, Shimizu T, Miura S, Ono Y, Kamei Y.

Sci Rep. 2019 Jul 18;9(1):10425. doi: 10.1038/s41598-019-46929-8.

49.

Renal impairment is closely associated with plasma aldosterone concentration in patients with primary aldosteronism.

Kawashima A, Sone M, Inagaki N, Takeda Y, Itoh H, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Kawashima J, Fujita M, Miyauchi S, Okamura S, Fukuoka T, Yanase T, Izawa S, Yoshikawa Y, Hashimoto S, Yamada M, Kai T, Suzuki T, Naruse M.

Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0047.R2. doi: 10.1530/EJE-19-0047. [Epub ahead of print]

PMID:
31319380
50.

Development of a thrombus in the superior mesenteric artery associated with sequential therapy with tyrosine kinase inhibitors for hepatocellular carcinoma.

Nawa T, Katayama K, Kiyota R, Imai T, Abe Y, Hasegawa N, Takada R, Fukutake N, Ikezawa K, Sakakibara M, Fujita M, Ohkawa K.

Clin J Gastroenterol. 2019 Jul 17. doi: 10.1007/s12328-019-01021-6. [Epub ahead of print]

PMID:
31317371

Supplemental Content

Loading ...
Support Center